Ani pharmaceuticals announces the launch of misoprostol tablets

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (“ani” or the “company”) (nasdaq: anip) today announced the launch of misoprostol tablets, 100 mcg and 200 mcg. ani's misoprostol tablets are the generic version of the reference listed drug (rld) cytotec®. the current annual u.s. market for misoprostol tablets, 100 mcg and 200 mcg is approximately $15.3 million, according to iqvia/ims health, a leading healthcare data and analytics provider. "we are pleased to announce the launch of a
ANIP Ratings Summary
ANIP Quant Ranking